PedAM
Pediatric Disease Annotations & Medicines
| Disease | ischemic stroke |
| Phenotype | C0026265|mitral valve disease |
| Sentences | 1 |
| PubMedID- 21847335 | [table 1].anticoagulation should be considered for all patients who have ischemic stroke associated with mitral valve disease, prosthetic heart valves, or within 3 months of myocardial infarction.anticoagulation should not be started until brain imaging has excluded hemorrhage, and 14 days have passed from the onset of a disabling ischemic stroke (except when a demonstrable intracardiac thrombus is present).anticoagulation should not be used for patients in sinus rhythm unless cardiac embolism is suspected.for effective anticoagulation target, inr is 2.5 (range 2.0-3.0) except for mechanical cardiac valves (3.0: range 2.5-3.5). |
Page: 1